Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

GAM: February is choppy across many hedge funds asset classes

Tuesday, March 05, 2013

From Komfie Manalo, Opalesque Asia – The month of February was rough sailing for many hedge funds asset classes and continued the same price trends in January, said the latest GAM Insight.

GAM said in the report, "Markets then reversed and consolidated, driven by concerns around the Italian elections and the release of the U.S. FOMC meeting minutes. The meeting minutes showed an unusually large number of committee members questioning the efficacy and risks associated with continued large-scale quantitative easing. Currencies continued to be volatile, with sterling weakening materially, the Japanese yen consolidating but weakening slightly over the month, and the trade-weighted US dollar index regaining some of its safe-haven appeal – ending up 3.5% for the month."

According to GAM, February offered the same result as January when equities saw a broad rally while the Japanese yen slid further.

It added that currencies remain volatile with the sterling continuing its downward spiral and the consolidated Japanese yen failed to bring the currency to a rebound. However, the trade-weighted U.S. dollar index regained some of its safe-haven appeal and was up 3.5% last month.

"The MSCI World index gave up its early gains and ended the month marginally positive, whereas the Barclays Global Aggregate Bond index was down 0.9%, both in U.S. Dollar terms. On the macroeconomic front, expectations for Eu......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for